Actively Recruiting
Effect of Electroacupuncture on Benign Prostatic Hyperplasia
Led by Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Updated on 2024-07-18
306
Participants Needed
1
Research Sites
146 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study aims to assess the efficacy and safety of electroacupuncture among men with benign prostatic hyperplasia (BPH), compared with sham electroacupuncture.
CONDITIONS
Official Title
Effect of Electroacupuncture on Benign Prostatic Hyperplasia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of benign prostatic hyperplasia according to European Association of Urology guidelines
- Male participants aged between 40 and 80 years
- Experiencing lower urinary tract symptoms for at least three months
- International Prostate Symptom Score (IPSS) total score of 8 or higher
- Prostate volume of 20 mL or more
- Urinary peak flow rate (Qmax) of 15 mL/s or less
- Willingness to participate voluntarily and signed written informed consent
You will not qualify if you...
- Post-void residual urine volume of 150 mL or more
- Acute urinary retention or catheterization for outflow obstruction within the past 3 months (except post-surgical disposable catheterization)
- Prostate cancer or prostate-specific antigen (PSA) level of 4.0 ng/mL or higher
- Neurogenic lower urinary tract dysfunction, prostatitis, uncontrolled symptomatic urinary tract infections, urethral strictures, bladder diverticula, bladder stones, bladder cancer, or history of genitourinary surgery
- Previous acupuncture treatment for BPH in the last month or use of alpha-blockers, 5-alpha-reductase inhibitors, muscarinic receptor antagonists, or other specific medications in the past two weeks unless stable 5-alpha-reductase inhibitor use for over three months
- Severe lung, heart, liver, kidney, metabolic, or mental illness; coagulation dysfunction; or obvious cognitive dysfunction
- Installed cardiac pacemaker, allergy to metal, severe fear of acupuncture, or inability to tolerate electroacupuncture stimulation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China, 100053
Actively Recruiting
Research Team
Z
Zhishun Liu
CONTACT
L
Lili Zhu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here